AVXL, SAVA, ANVS -- the non-amyloid trio -- all up
Post# of 1460
Maybe people are figuring out that, if a garbage drug that doesn't do anything can charge $56,000/year, a drug that ACTUALLY does some good will also be able to sell -- and hopefully, at a much more reasonable price.